Attachment A - Draft Statement of Work
Updated
A Word document (59 KB) attached to U.S. Food & Drug Administration (FDA) Office of Inspections and Investigations (OII) Biomanufacturing Principles and Processes Training Series, from the Food and Drug Administration. Due Dec 1, 2027, 12:00 PM (UTC-5).
File name: Attachment A - Draft Statement of Work.docx
The full file is for paid members, or buy this bid alone.
Preview
STATEMENT OF WORK
FOOD AND DRUG ADMINISTRATION (FDA)
OFFICE OF INSPECTIONS AND INVESTIGATIONS (OII)
BIOMANUFACTURING PRINCIPLES AND PROCESSES TRAINING SERIES
Background
Objective
Scope
Tasks
Deliverables
Contract Type
Place of Performance
Period of Performance
Assumptions and Constraints
Government Furnished Equipment/Information/Property
Authorized Contacts
Travel, Materials, and Incidental Services
Holidays and Government Closures
Government Contacts
508 Standard Requirements
Security Requirements
Background
The Food and Drug Administration (FDA) is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation's food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable, and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health. The U.S. Food and Drug Administration (FDA) Office of Inspections and Investigations (OII) coordinates domestic and foreign inspectional, quality and investigational activities across the field and at headquarters. In addition, OII works closely with other FDA Offices on compliance and enforcement activities and to implement policies related to the Pharmaceutical program. The Office of Training, Education, and Development’s (OTED) Division of Inspections and Investigations trains field and headquarter investigators and analysts to conduct inspections of biopharmaceutical and pharmaceutical manufacturing processes and practices for compliance with good manufacturing practices (GMP) regulations. The trainees for the Biomanufacturing Principles and Processes Curriculum will typically have five (5) or more years of agency experience and hold a Bachelor of Science degree. Some will have a background in chemistry, biochemistry, microbiology or engineering. OTED has created a comprehensive curriculum series to provide investigators with additional biological therapeutic drug training in the following areas: Product development and manufacturing processes
Facility and equipment design
Technology transfer
Manufacturing processes
Analytical Testing Methods
Objective
OTED requires one individual contractor to deliver an enhanced four-course training curriculum including course material, modules, webinars, and hands-on training, as necessary, to FDA investigators. This will allow FDA inspectors to experience the production of biological therapeutic drug products thereby enabling them to better understand biomanufacturing principles and processes to include facility equipment design, product manufacturing processes, analytical testing methods, and emerging technologies in biomanufacturing. The training will provide investigators with the skills and knowledge to determine areas of highest risk during inspections of biopharmaceutical manufacturing facilities.
The beginning of the document. Download the full file to read on.